Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for POCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 33.69M
December 31, 2025 22.90M
September 30, 2025 22.38M
June 30, 2025 19.79M
March 31, 2025 19.62M
December 31, 2024 17.51M
September 30, 2024 17.24M
June 30, 2024 16.91M
March 31, 2024 18.27M
December 31, 2023 17.70M
September 30, 2023 19.07M
June 30, 2023 19.74M
March 31, 2023 18.19M
December 31, 2022 17.47M
September 30, 2022 17.17M
June 30, 2022 16.70M
March 31, 2022 17.27M
December 31, 2021 16.89M
September 30, 2021 7.102M
June 30, 2021 6.261M
March 31, 2021 5.906M
December 31, 2020 5.863M
September 30, 2020 6.132M
June 30, 2020 6.352M
March 31, 2020 5.847M
Date Value
December 31, 2019 5.782M
September 30, 2019 6.037M
June 30, 2019 7.493M
March 31, 2019 3.636M
December 31, 2018 3.862M
September 30, 2018 2.311M
June 30, 2018 2.512M
March 31, 2018 2.092M
December 31, 2017 2.305M
September 30, 2017 1.921M
June 30, 2017 1.801M
March 31, 2017 2.028M
December 31, 2016 2.267M
September 30, 2016 1.940M
June 30, 2016 2.123M
March 31, 2016 2.042M
December 31, 2015 2.090M
September 30, 2015 1.722M
June 30, 2015 2.042M
March 31, 2015 2.224M
December 31, 2014 2.484M
September 30, 2014 2.244M
June 30, 2014 1.836M
March 31, 2014 1.895M
December 31, 2013 1.971M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
RxSight, Inc. 352.70M
Abbott Laboratories 109.22B
Align Technology, Inc. 6.418B
AngioDynamics, Inc. 267.16M
Accuray, Inc. 443.68M

Total Assets (Quarterly) Related Metrics